These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 11121512)
1. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Touyz RM; Schiffrin EL Pharmacol Rev; 2000 Dec; 52(4):639-72. PubMed ID: 11121512 [TBL] [Abstract][Full Text] [Related]
2. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II. Ohtsu H; Mifune M; Frank GD; Saito S; Inagami T; Kim-Mitsuyama S; Takuwa Y; Sasaki T; Rothstein JD; Suzuki H; Nakashima H; Woolfolk EA; Motley ED; Eguchi S Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1831-6. PubMed ID: 15994438 [TBL] [Abstract][Full Text] [Related]
3. Role of the actin cytoskeleton in angiotensin II signaling in human vascular smooth muscle cells. Touyz RM; Yao G; Schiffrin EL Can J Physiol Pharmacol; 2005 Jan; 83(1):91-7. PubMed ID: 15759055 [TBL] [Abstract][Full Text] [Related]
4. Animal model for angiotensin II effects in the internal anal sphincter smooth muscle: mechanism of action. Fan YP; Puri RN; Rattan S Am J Physiol Gastrointest Liver Physiol; 2002 Mar; 282(3):G461-9. PubMed ID: 11841996 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II signal transduction and the mitogen-activated protein kinase pathway. Duff JL; Marrero MB; Paxton WG; Schieffer B; Bernstein KE; Berk BC Cardiovasc Res; 1995 Oct; 30(4):511-7. PubMed ID: 8574999 [TBL] [Abstract][Full Text] [Related]
6. Recent advances in angiotensin II signaling. Touyz RM; Berry C Braz J Med Biol Res; 2002 Sep; 35(9):1001-15. PubMed ID: 12219172 [TBL] [Abstract][Full Text] [Related]
7. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation. Kyaw M; Yoshizumi M; Tsuchiya K; Kagami S; Izawa Y; Fujita Y; Ali N; Kanematsu Y; Toida K; Ishimura K; Tamaki T Mol Pharmacol; 2004 Apr; 65(4):832-41. PubMed ID: 15044612 [TBL] [Abstract][Full Text] [Related]
8. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation. Nagata D; Takeda R; Sata M; Satonaka H; Suzuki E; Nagano T; Hirata Y Circulation; 2004 Jul; 110(4):444-51. PubMed ID: 15262850 [TBL] [Abstract][Full Text] [Related]
9. Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells. Min LJ; Mogi M; Li JM; Iwanami J; Iwai M; Horiuchi M Circ Res; 2005 Sep; 97(5):434-42. PubMed ID: 16081869 [TBL] [Abstract][Full Text] [Related]
10. PPARalpha activator fenofibrate modulates angiotensin II-induced inflammatory responses in vascular smooth muscle cells via the TLR4-dependent signaling pathway. Ji YY; Liu JT; Liu N; Wang ZD; Liu CH Biochem Pharmacol; 2009 Nov; 78(9):1186-97. PubMed ID: 19576184 [TBL] [Abstract][Full Text] [Related]
13. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Yoshizumi M; Tsuchiya K; Suzaki Y; Kirima K; Kyaw M; Moon JH; Terao J; Tamaki T Biochem Biophys Res Commun; 2002 May; 293(5):1458-65. PubMed ID: 12054679 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II stimulation of vascular smooth muscle. Griendling KK; Tsuda T; Berk BC; Alexander RW J Cardiovasc Pharmacol; 1989; 14 Suppl 6():S27-33. PubMed ID: 2478821 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin II up-regulates the leukemia-associated Rho guanine nucleotide exchange factor (RhoGEF), a regulator of G protein signaling domain-containing RhoGEF, in vascular smooth muscle cells. Ying Z; Jin L; Palmer T; Webb RC Mol Pharmacol; 2006 Mar; 69(3):932-40. PubMed ID: 16354763 [TBL] [Abstract][Full Text] [Related]
17. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways. Montezano AC; Callera GE; Yogi A; He Y; Tostes RC; He G; Schiffrin EL; Touyz RM Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1511-8. PubMed ID: 18467645 [TBL] [Abstract][Full Text] [Related]
18. Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation. Touyz RM; Cruzado M; Tabet F; Yao G; Salomon S; Schiffrin EL Can J Physiol Pharmacol; 2003 Feb; 81(2):159-67. PubMed ID: 12710530 [TBL] [Abstract][Full Text] [Related]
19. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Touyz RM Exp Physiol; 2005 Jul; 90(4):449-55. PubMed ID: 15890798 [TBL] [Abstract][Full Text] [Related]
20. Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells. Rautureau Y; Paradis P; Schiffrin EL Steroids; 2011 Aug; 76(9):834-9. PubMed ID: 21371487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]